These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10444166)

  • 1. Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562.
    Dumontet C; Fabianowska-Majewska K; Mantincic D; Callet Bauchu E; Tigaud I; Gandhi V; Lepoivre M; Peters GJ; Rolland MO; Wyczechowska D; Fang X; Gazzo S; Voorn DA; Vanier-Viornery A; MacKey J
    Br J Haematol; 1999 Jul; 106(1):78-85. PubMed ID: 10444166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common resistance mechanisms to nucleoside analogues in variants of the human erythroleukemic line K562.
    Dumontet C; Bauchu EC; Fabianowska K; Lepoivre M; Wyczechowska D; Bodin F; Rolland MO
    Adv Exp Med Biol; 1999; 457():571-7. PubMed ID: 10500836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.
    Klanova M; Lorkova L; Vit O; Maswabi B; Molinsky J; Pospisilova J; Vockova P; Mavis C; Lateckova L; Kulvait V; Vejmelkova D; Jaksa R; Hernandez F; Trneny M; Vokurka M; Petrak J; Klener P
    Mol Cancer; 2014 Jun; 13():159. PubMed ID: 24972933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
    Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
    Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues].
    Jordheim LP; Galmarini CM; Dumontet C
    Bull Cancer; 2005 Mar; 92(3):239-48. PubMed ID: 15820918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5'-nucleotidase activity.
    Schirmer M; Stegmann AP; Geisen F; Konwalinka G
    Exp Hematol; 1998 Dec; 26(13):1223-8. PubMed ID: 9845378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
    Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ
    Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.
    Månsson E; Spasokoukotskaja T; Sällström J; Eriksson S; Albertioni F
    Cancer Res; 1999 Dec; 59(23):5956-63. PubMed ID: 10606241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New prospects in the treatment of indolent lymphomas with purine analogues.
    Cheson BD
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
    Clarke ML; Mackey JR; Baldwin SA; Young JD; Cass CE
    Cancer Treat Res; 2002; 112():27-47. PubMed ID: 12481710
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.
    Gourdeau H; Clarke ML; Ouellet F; Mowles D; Selner M; Richard A; Lee N; Mackey JR; Young JD; Jolivet J; Lafrenière RG; Cass CE
    Cancer Res; 2001 Oct; 61(19):7217-24. PubMed ID: 11585758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside analogues: mechanisms of drug resistance and reversal strategies.
    Galmarini CM; Mackey JR; Dumontet C
    Leukemia; 2001 Jun; 15(6):875-90. PubMed ID: 11417472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide.
    Lotfi K; Månsson E; Chandra J; Wang Y; Xu D; Knaust E; Spasokoukotskaja T; Liliemark E; Eriksson S; Albertioni F
    Br J Haematol; 2001 May; 113(2):339-46. PubMed ID: 11380397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
    Bergman AM; Pinedo HM; Jongsma AP; Brouwer M; Ruiz van Haperen VW; Veerman G; Leyva A; Eriksson S; Peters GJ
    Biochem Pharmacol; 1999 Feb; 57(4):397-406. PubMed ID: 9933028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular resistance against troxacitabine in human cell lines and pediatric patient acute myeloid leukemia blast cells.
    Adema AD; Zuurbier L; Floor K; Hubeek I; Kaspers GJ; Albertoni F; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):981-6. PubMed ID: 17065050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780.
    Ruiz van Haperen VW; Veerman G; Eriksson S; Stegmann AP; Peters GJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):35-41. PubMed ID: 7481843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside analogues in the treatment of haematological malignancies.
    Johnson SA
    Expert Opin Pharmacother; 2001 Jun; 2(6):929-43. PubMed ID: 11585009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine.
    Braess J; Wegendt C; Jahns-Streubel G; Kern W; Keye S; Unterhalt M; Schleyer E; Hiddemann W
    Br J Haematol; 2000 May; 109(2):388-95. PubMed ID: 10848830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line.
    Hubeek I; Peters GJ; Broekhuizen AJ; Kaspers GJ
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1513-6. PubMed ID: 15571288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of deoxycytidine kinase by various nucleoside analogues.
    Spasokoukotskaja T; Sasvári-Székely M; Hullán L; Albertioni F; Eriksson S; Staub M
    Adv Exp Med Biol; 1998; 431():641-5. PubMed ID: 9598144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.